A Chinese male patient at the age of 46 years was first admitted to our hospital for diarrhea, alopecia, nail separation, and skin hyperpigmentation over a period of 4 months. He was diagnosed with CCS and concurrent colonic adenocarcinoma. Endoscopy at follow-up showed multiple polyps lining the stomach [ Figure 1A ] and colon [ Figure 1B ]. The patient was detected with spermatogonia at the age of 30 years and small cell lung cancer at the age of 58 years. Additionally, he had a family history of gastric cancer affecting his father and sister.
The coexistence of complex cancer history and CCS made this patient an interesting rare case. Therefore, WES analysis was considered to explore whether some germline mutations may account for the susceptibility to CCS and concurrent malignancies. DNA samples of this patient were sequenced on the Illumina HiSeq 2500 platform (Illumina, San Diego, CA, USA) using pair-end method with a sequencing depth of 50Â. The germline mutations identified by WES were listed in Supplementary Table 1 , http://links.lww.com/CM9/A111. Rare missense mutations with a frequency <0.05 were selected for further analysis according to the 1000genome-eas (http://www. internationalgenome.org/category/population/) and ExAC (http://exac.broadinstitute.org) databases. GeneCodis3 (http://genecodis.cnb.csic.es/analysis) was used to designate the functional annotations to genes that contain more than one rare missense mutation. A total of 814 variants in 625 genes were identified, among which 37 genes have two rare missense mutations and 24 genes have more than three missense mutations. Functional annotations of the above genes identified nine genes related to known diseases [Supplementary Table 2 , http://links.lww.com/ CM9/A111]. Further literature search indicated that MUC3A (OMIM: 158371) and MUC5B (OMIM: 600770) may be involved in the pathogenesis of both inflammatory diseases and cancers. [4, 5] Bioinformatics analysis predicted that the mutations in MUC3A may lead to changes in its O-glycosylation site and phosphorylation site. However, the mutations in MUC5B was not predicted to cause changes in protein structure and function. Immunohistochemical staining in the gastric hyperplastic polyps of this patient showed reduced MUC3A expression compared to normal mucosa when MUC1 and MUC2 expression remain unchanged [ Figure 1C -H].
contribute to the pathogenesis of this patient. Further investigation of germline and somatic mutations in more CCS patients is needed to elucidate the molecular landscape of this disease and provide more insights for the concurrent carcinogenesis.
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